Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Atherogenics

1993 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Bankr. Admin/Reorg LATEST DEAL TYPE
Description

Developer of treatments for inflammatory disease. The company develops novel drugs for diabetes and coronary heart disease.

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Primary Office
  • 8995 Westside Parkway
  • Alpharetta, GA 30004
  • United States

+1 (678) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Atherogenics’s full profile, request a free trial.

Atherogenics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Admin/Reorg 22-Jun-2009 Completed Bankruptcy: Admin/Reorg
6. Convertible Debt 14-Aug-2003 0000 00000 Completed Generating Revenue
5. 2PO 29-Jun-2001 000.00 000.00 Completed Generating Revenue
4. IPO 09-Aug-2000 0000 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Sep-1999 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series B) Completed Generating Revenue
1. Early Stage VC (Series A) Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »